Avemar


Our mission is to provide an all natural, clinically proven, effective nutritional supplement that has been helping to improve the quality of life of oncological patients over many years. Avemar is a dietary supplement available in the form of granulate or film-coated tablet. Avemar is recognised in many countries around the globe.


What is Avemar?


Avemar is an all-natural, clinically proven, dietary supplement for cancer patients. Medical experts recognize Avemar as an effective supportive cancer treatment and recommend complementing the diet of concerned patients with Avemar. Scientific studies showed that Avemar also enhances the efficacy of conventional oncological treatments (surgery, radio-, chemo- and immunotherapy). With regular intake of Avemar, patients can relish a better quality of life and can enjoy a better lifestyle. Avemar is available in granulate and film-coated tablet form.

The active ingredient is Avemar pulvis, an all-natural compound made from fermented wheat germ extract using patented biotechnological processes. Since the invention of Avemar pulvis significant research has been undertaken - not only in the laboratory, but in test animals and human cancer patients as well. Numerous scientific studies have been conducted to study its safety profile and its effectiveness, including in vitro, in vivo and human clinical research. Over 100 reports have been written for presentation or publication since 1998, and over 33 peer-reviewed scientific papers are currently accessible at PubMed database. All scientific publications are accessible at the official Avemar Research website.

Avemar has been registered as “dietary food for special medical purposes for cancer patients” since 2002. Avemar also gained the NutrAward for the “Best New Product of the Year” in California, USA in 2006.

For more information about recommended dosage and application please click here!

 



For medical professionals & How does it work?


Since the discovery of Avemar, more than 13 years of scientific studies have been completed to support its safety and effectiveness, including in vitro, in vivo and other clinical researches. Those years have provided consistent studies supporting Avemar’s ability to promote a better quality of life and maintain a healthy lifestyle in cancer patients undergoing clinical oncological treatments, including chemotherapy and radiotherapy. Avemar has been the subject of over 100 scientific studies and 33 PubMed publications. Avemar is also included in database of the Memorial Sloan-Kettering Cancer Center.

The Avemar Research Program has been funded by many government organizations such as: The Ministry of Education, Biotechnology and OTKA [Scientific Research Foundation] in Hungary, The Ministry of Health and the Ministry of Science and Technology in Spain, The UCLA, General Clinical Research Center and Clinical Nutrition Research Unit in the US, Inco-Copernicus from the European Union and The Scientific Program, NATO.

More than 100 published papers have reviewed the clinical and experimental results obtained with this extract and have also been published in prestigious journals. In vitro studies of cell cultures, animal studies and clinical trials with over 1200 people to date, have been undertaken in Hungary, Israel, Spain, Italy, Russia, the US and Australia to name a few. For more information please visit: http://research.avemar.com

Learn more about the:

molecular targets of Avemar »
the effects of Avemar on cancer cell metabolism »
the effects of Avemar on the Immune system »


Avemar has been shown to have many mechanisms of action, not surprising since as a natural compound, it is composed of a naturally occurring blend of many medicinally active constituents.

 


 

Avemar World Wide


Over the years Biropharma Ltd., manufacturer of the original Avemar pulvis, has established business relationships worldwide. Thanks to our exclusive distributional partners today Avemar is available in many countries around the globe.

 

Please contact your local Avemar distributor to order Avemar


Avemar Research Program


Avemar has been recognised and studied worldwide since 1998. As in vitro, in vivo and clinical studies provided further evidence of its safety and effectiveness in the supplementation of oncological treatments, Avemar was registered as “dietary food for special medical purposes for cancer patients” in 2002. Since the discovery of Avemar pulvis, the active ingredient of Avemar, over 13 years of scientific study has been conducted to support its safety and effectiveness, including in vitro, in vivo and human clinical research. Most of the prestigious publications are also published at the PubMed database.

To read more about Avemar and the Avemar Research Program please visit the official research website at: http://research.avemar.com

In scientific studies Avemar:

  • Improved the overall survival, metastases-free survival and progression-free survival of certain cancer patients
  • Improved the tolerance for surgeries, chemotherapy and radiotherapy
  • Enhanced and not interfered with the anticancer effects of chemotherapies
  • Decreased the severity of the immune suppressive effects of surgery, radiation and chemotherapy
  • Enhanced the quality of life and physical condition of early and late stage cancer patients (less fatigue, less pain and increased appetite)
  • Up regulated the Th1 (cellular) immune function, while inhibiting Th2 (humoral) immune function
  • Stimulated cancer cell apoptosis (programmed cell death)
  • Enhance the ability of NK cells to identify and kill cancerous and other target cells by down regulating the presentation of MHC-I molecules on infected cells
  • Stimulated the production of TNF-alpha by macrophages
  • Enhanced the tumour invasive potential of immune system cells by up regulating ICAM-A molecules in micro-vascular endothelial cells
  • Modified the glucose metabolism of cancer cells by decreasing intracellular glucose uptake and shifting glucose away from DNA synthesis


Learn more about the benefits of Avemar at: http://research.avemar.com



For more scientific information please refer to these following links

List of all publications  http://research.avemar.com/en/all_articles
List of review articles  http://research.avemar.com/en/review_articles
List of general articles http://research.avemar.com/en/general_articles
Human Clinical Trials http://research.avemar.com/en/human_clinical_trials
in vivo (animal trials)  http://research.avemar.com/en/in_vivo_animal_studies
in vitro (cell line studies) http://research.avemar.com/en/in_vitro_cell_line_studies

Specific Cancer Studies including, Breast Cancer, Colon Cancer,Gastric Cancer, Melanoma,Lung Cancer, Head and Neck, Pancreatic Cancer, Other Cancers, click here.http://research.avemar.com/en/specific_studies

FAQ - Click here http://www.avemar.com/avemar_products/questions_and_answers

 


If you are a practitioner and would like to access these unique products and services please contact our friendly customer service team or alternatively on Freephone NZ 0800 88 44 33 or AUS 1800 177 959.

If you are a patient and would like to access these products and services please click here to request your nearest practitioner